<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">892</journal-id><journal-id journal-id-type="pmc-domain">vetres</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6979349</article-id><article-id pub-id-type="pmcid-ver">PMC6979349.1</article-id><article-id pub-id-type="pmcaid">6979349</article-id><article-id pub-id-type="pmcaiid">6979349</article-id><article-id pub-id-type="pmid">31973749</article-id><article-id pub-id-type="doi">10.1186/s13567-020-0735-y</article-id><article-id pub-id-type="publisher-id">735</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Live vaccine consisting of attenuated <italic toggle="yes">Salmonella</italic> secreting and delivering <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent <italic toggle="yes">Brucella abortus</italic> 544 challenge</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Senevirathne</surname><given-names initials="A">Amal</given-names></name><address><email>amalsenevirathne@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hewawaduge</surname><given-names initials="C">Chamith</given-names></name><address><email>hewa889@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2028-2207</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="JH">John Hwa</given-names></name><address><email>johnhlee@jbnu.ac.kr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0470 4320</institution-id><institution-id institution-id-type="GRID">grid.411545.0</institution-id><institution>College of Veterinary Medicine, </institution><institution>Chonbuk National University, </institution></institution-wrap>Iksan Campus, Iksan, 54596 Republic of Korea </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="ppub"><year>2020</year></pub-date><volume>51</volume><issue-id pub-id-type="pmc-issue-id">349644</issue-id><elocation-id>6</elocation-id><history><date date-type="received"><day>18</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>6</day><month>1</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>01</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>29</day><month>01</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-21 22:25:12.587"><day>21</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13567_2020_Article_735.pdf"/><abstract id="Abs1"><p id="Par1">The present study employs the <italic toggle="yes">Brucella abortus</italic> L7/L12 antigen in a <italic toggle="yes">Salmonella</italic> secretion platform and investigates its ability to induce protective immune responses against wild type challenge in BALB/c mice. The highly conserved L7/L12 open reading frame was PCR amplified from <italic toggle="yes">B. abortus</italic> and cloned into a prokaryotic expression vector, pJHL65, directly under the beta-lactamase secretory signal. The plasmid constructs pJHL65::L7/L12 was then transformed into an attenuated <italic toggle="yes">Salmonella</italic> Typhimurium strain, JOL1800 (<italic toggle="yes">&#8710;lon</italic>, <italic toggle="yes">&#8710;cpxR</italic>, <italic toggle="yes">&#8710;asd</italic>, and <italic toggle="yes">&#8710;rfaL</italic>), and protein secretion was verified by Western blot. Three mice groups were inoculated with either phosphate-buffered saline (PBS), vector-only control, or the vaccine strain secreting L7/L12 antigen. Assessment of humoral and cell-mediated immune responses revealed successful elicitation of <italic toggle="yes">Brucella</italic> antigen-specific Th1 and Th2 immune responses that were significantly higher than PBS and vector control groups. The immune responses were confirmed by splenocyte proliferation assay, flow cytometry analysis for CD4+ and CD8+ markers, and RT-PCR based cytokine profiling upon restimulation with L7/L12 purified antigen. Results indicate that immunization with <italic toggle="yes">Salmonella</italic> secreting L7/L12 antigen demonstrated significant enhancement of cell-mediated immune (CMI) responses in immunized mice. The overall effectiveness of the immunization was evaluated by challenging with virulent <italic toggle="yes">B. abortus</italic> that revealed significant reduction in <italic toggle="yes">Brucella</italic> colonization in spleen and liver tissues in <italic toggle="yes">Salmonella</italic> L7/L12 immunized mice. Delivery of <italic toggle="yes">Brucella</italic> protective antigen L7/L12 using the <italic toggle="yes">Salmonella</italic> secretion system can effectively accomplish immunogenic advantages of both <italic toggle="yes">Salmonella</italic> and L7/L12 to derive robust CMI responses and induce humoral immunity to protect against <italic toggle="yes">Brucella</italic> infection in the mouse model.</p></abstract><funding-group><award-group><funding-source><institution>National Research Foundation of Korea</institution></funding-source><award-id>2019R1A6A1A03033084</award-id><principal-award-recipient><name name-style="western"><surname>Lee</surname><given-names>John Hwa</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2"><italic toggle="yes">Brucella abortus</italic> is a zoonotic bacterial pathogen within the genus <italic toggle="yes">Brucella</italic>. It induces abortions, placental retention, and infertility in ruminants and undulant fever in humans with occasional chronic infections. As an intracellular pathogen, it proliferates in both phagocytic [<xref ref-type="bibr" rid="CR1">1</xref>] and non-phagocytic cells [<xref ref-type="bibr" rid="CR2">2</xref>] in the infected host. Host resistance to <italic toggle="yes">B. abortus</italic> mainly depends on interferon-gamma (IFN-&#947;) involved cell-mediated immune responses [<xref ref-type="bibr" rid="CR3">3</xref>]. Up regulation of IFN-&#947; cytokine is essential to induce the anti-<italic toggle="yes">Brucella</italic> activity of macrophages that helps to clear <italic toggle="yes">Brucella</italic> from the infected host [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par3">Among antigens that efficiently induce anti-<italic toggle="yes">Brucella</italic> cell-mediated immune (CMI) responses, <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 has been recognized as a plausible candidate in recent research studies. These experiments have shown that L7/L12 can efficiently induce protective immune responses in the form of subunit or DNA vaccines [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Apart from CMI responses, antibody-mediated humoral responses also play a vital role during <italic toggle="yes">B. abortus</italic> infection. Elicitation of mucosal immune responses is effective during the early phase of infection on mucosal surfaces, where the complement killing system can reduce the proportion of <italic toggle="yes">Brucella</italic> entering the intracellular environment [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, an effective prevention strategy for <italic toggle="yes">B. abortus</italic> should ideally harness both CMI responses and humoral immune responses in the immunized host [<xref ref-type="bibr" rid="CR8">8</xref>]. Utilizing an attenuated systemic pathogen such as <italic toggle="yes">Salmonella</italic> for the delivery of protective antigens can capitalize on both CMI and humoral responses considering their mechanism in host immune stimulation. Based on&#160;the above fact, here we utilize <italic toggle="yes">Salmonella</italic> to deliver <italic toggle="yes">Brucella</italic> antigen (L7/L12). As an intracellular pathogen, <italic toggle="yes">Salmonella</italic> can invade into host macrophages and lymphoid organs such as the spleen and liver [<xref ref-type="bibr" rid="CR9">9</xref>]. Thus, <italic toggle="yes">Salmonella</italic> can effectively deliver heterologous antigens directly into macrophages, other cells, and tissues where antigen-presenting cells can process and recognize <italic toggle="yes">Brucella</italic> antigens for adaptive immune responses and fight against infections. Further, <italic toggle="yes">Salmonella</italic> can overcome mucosal barriers and actively penetrate the host tissue environment that is essential to maximize antigen presentation [<xref ref-type="bibr" rid="CR10">10</xref>]. In addition, sufficient attenuation can also be incorporated into the <italic toggle="yes">Salmonella</italic> genome with relative ease due to its genome that&#160;has been thoroughly investigated with most virulence-related genes being&#160;identified.</p><p id="Par4">Despite scientific advancement in DNA vaccine technology during recent years, plasmid delivery in in vivo conditions remains a significant challenge. Intracellular delivery, entry into the cell nucleus, and expression of the intended protein is a relatively inefficient process. To overcome such inefficacy in DNA vaccines, high quantities of plasmid DNA usually have to be utilized with multiple booster applications [<xref ref-type="bibr" rid="CR11">11</xref>]. Such inconveniences may be avoided by using an efficient <italic toggle="yes">Salmonella</italic> mediated secretion system that does not require induction or multiple immunizations. In our previous study, an attenuated <italic toggle="yes">Salmonella</italic> Typhimurium strain, JOL1800, was constructed with specific deletions in the <italic toggle="yes">lon</italic>, <italic toggle="yes">cpxR</italic>, and <italic toggle="yes">rfaL</italic> genes. The resulting strain has impaired intracellular survival due to loss of <italic toggle="yes">lon</italic> and <italic toggle="yes">cpxR</italic> virulence-related genes [<xref ref-type="bibr" rid="CR12">12</xref>] and has a truncated lipopolysaccharide structure due to a <italic toggle="yes">rfaL</italic> gene mutation. The resulting JOL1800 DIVA (Differentiating infected from vaccinated animals) is ideal for vaccine studies. Besides, this strain is aspartate dehydrogenase auxotrophic (<italic toggle="yes">&#916;asd</italic>) and can stably harbor plasmid constructs complemented with <italic toggle="yes">asd</italic> gene [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par5">The aim of the present study is to design a safe <italic toggle="yes">Brucella</italic> vaccine that is applicable in both human and animal models for efficient elicitation of humoral and cell-mediated immune responses utilizing a <italic toggle="yes">Salmonella</italic> secretion and delivery system. The present <italic toggle="yes">Salmonella</italic> strain, JOL1800, is an <italic toggle="yes">asd</italic> auxotrophic mutant that can stably carry an <italic toggle="yes">asd</italic> complemented plasmid pJHL65, which contains fusion of <italic toggle="yes">B. abortus</italic> ribosomal protein L7/L12 with the beta-lactamase (<italic toggle="yes">bla</italic>) secretory signal sequence. Attenuated <italic toggle="yes">Salmonella</italic> can secrete heterologous <italic toggle="yes">Brucella</italic> antigens into the host by crossing the periplasmic barrier acting as an intracellular pathogen. Due to impaired virulence, attenuated <italic toggle="yes">Salmonella</italic> does not cause systemic infection and only provides transient immune stimulation in the host. We have observed robust elicitation of both humoral and cellular immune responses in immunized mice with significant protection against virulent challenges. We have observed <italic toggle="yes">Salmonella</italic> alone carrying the empty plasmid vector provide considerable protection against the virulent <italic toggle="yes">Brucella</italic> challenge that may be attributed to <italic toggle="yes">Salmonella</italic> induced immune stimulation. The results indicate&#160;that <italic toggle="yes">Salmonella</italic> is an excellent antigen delivery system for specific induction of anti-<italic toggle="yes">Brucella</italic> immunity that takes advantage of both <italic toggle="yes">Salmonella</italic> and L7/L12 immunogenic capabilities. This provides an easy and effective strategy for mass production of an anti-<italic toggle="yes">Brucella</italic> vaccine that is applicable to&#160;both humans and animals. In the present study, we demonstrated that a <italic toggle="yes">Salmonella</italic> system could be effectively utilized for delivery of <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12. This elicits robust anti-<italic toggle="yes">Brucella</italic> protective immunity by achieving the immunogenic advantages of <italic toggle="yes">Salmonella</italic> and L7/L12 as a protective antigen to be used in the battle against <italic toggle="yes">Brucella</italic> infection.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Bacterial strains and plasmids</title><p id="Par6">The bacterial strains, plasmids, and primers used in this experiment are listed in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. Attenuated <italic toggle="yes">Salmonella</italic> and <italic toggle="yes">Escherichia coli</italic> strains were routinely grown at 37&#160;&#176;C in Luria&#8211;Bertani (LB) broth or agar with or without appropriate antibiotics unless otherwise indicated. <italic toggle="yes">B. abortus</italic> 544 strain was grown in <italic toggle="yes">Brucella</italic> medium (BD, Sparks, USA) at 37&#160;&#176;C in a 5% CO<sub>2</sub> atmosphere without antibiotics. Appropriate biosafety measures were enforced while handling <italic toggle="yes">B. abortus</italic>, a biosafety level 3 microorganism.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p><bold>Bacterial strains, plasmids, and primers</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Strain/Plasmid</th><th align="left" colspan="1" rowspan="1">Description</th><th align="left" colspan="1" rowspan="1">Reference</th></tr></thead><tbody><tr><td align="left" colspan="3" rowspan="1"><italic toggle="yes">S</italic>. Typhimurium</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;JOL1800</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">&#8710;lon, &#8710;cpxR, &#8710;asd</italic> and <italic toggle="yes">&#8710;wpaB</italic> mutant of <italic toggle="yes">S.</italic> Typhimurium</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;JOL2273</td><td align="left" colspan="1" rowspan="1">JOL1800 containing pJHL65:: L7/L12 and expressing l7/L12</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;JOL2080</td><td align="left" colspan="1" rowspan="1">JOL1800 carrying the empty vector</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="3" rowspan="1"><italic toggle="yes">E. coli</italic></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;BL21(DE3)pLysS</td><td align="left" colspan="1" rowspan="1">F<sup>&#8722;</sup>, <italic toggle="yes">omp</italic>T, <italic toggle="yes">hsd</italic>S<sub>B</sub> (r<sub arrange="stack">B</sub><sup arrange="stack">&#8722;</sup>, m<sub arrange="stack">B</sub><sup arrange="stack">&#8722;</sup>), <italic toggle="yes">dcm, gal</italic>, &#955; (DE3), pLysS, Cm<sup>r</sup></td><td align="left" colspan="1" rowspan="1">Progma, USA</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;JOL1921</td><td align="left" colspan="1" rowspan="1">BL21(DE3)pLysS harboring pET28a&#8201;+&#8201;:: L7/L12</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="3" rowspan="1">Plasmid</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;pET28a(+)</td><td align="left" colspan="1" rowspan="1">IPTG-inducible expression vector; Kanamycin resistant</td><td align="left" colspan="1" rowspan="1">Novagen, USA</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;pET28a&#8201;+&#8201;:: L7/L12</td><td align="left" colspan="1" rowspan="1">pET28a&#8201;+&#8201;derivative containing L7/L12</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;pJHL65</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">asd</italic><sup>+</sup> vector, pBR ori, &#946;-lactamase signal sequence-based periplasmic secretion plasmid, 6xHis, high copy number</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;pJHL65:: L7/L12</td><td align="left" colspan="1" rowspan="1">pJHL65 harboring L7/L12</td><td align="left" colspan="1" rowspan="1">Lab stock</td></tr><tr><td align="left" colspan="3" rowspan="1">Primer</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;L7/L12 EcoRI F</td><td align="left" colspan="1" rowspan="1">5&#8242;-AGAGGAATTCATGGCTGATCTCGCAAAGAT-3&#8242;</td><td align="left" colspan="1" rowspan="1">This study</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;L7/L12 HindIII R</td><td align="left" colspan="1" rowspan="1">5&#8242;-AGAGAAGCTTTTACTTGAGTTCAACCTTGG-3&#8242;</td><td align="left" colspan="1" rowspan="1">This study</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec4"><title>Construction of attenuated <italic toggle="yes">Salmonella</italic> mutant delivering <italic toggle="yes">Brucella</italic> antigen</title><p id="Par7">The&#160;construction of the <italic toggle="yes">asd</italic> complemented pJHL65 plasmid that constitutively expresses heterologous antigens was described in a previous report [<xref ref-type="bibr" rid="CR7">7</xref>]. Briefly, <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 gene was PCR amplified from the <italic toggle="yes">B. abortus</italic> genome and cloned in-frame immediately downstream to the beta-lactamase (<italic toggle="yes">bla</italic>) secretory signal. Thereby, proteins can be externalized using a Type II secretory system. The novel plasmid construct was denoted as pJHL65:: <italic toggle="yes">L7/L12</italic>. The recombinant plasmid was then transformed into an <italic toggle="yes">asd</italic> mutant auxotrophic <italic toggle="yes">Salmonella</italic> mutant strain JOL1800 (<italic toggle="yes">&#8710;lon</italic>, <italic toggle="yes">&#8710;cpxR</italic>, <italic toggle="yes">&#8710;asd</italic>, and <italic toggle="yes">&#8710;rfaL</italic>). The resultant strain was designated as JOL2273. The presence of the respective gene in the attenuated <italic toggle="yes">Salmonella</italic> strain was confirmed by PCR. Secretion of <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 by the attenuated <italic toggle="yes">Salmonella</italic> strain was confirmed by Western blot analysis utilizing HRP labeled anti-his tag antibody. To generate purified protein, the L7/L12 coding sequence was cloned into a pET28a+ vector (Novagen, Madison, WI, USA). The recombinant plasmid was then transformed into <italic toggle="yes">E. coli</italic> BL21 DE strain (Novagen) for overexpression and purification. The expressed protein was purified using Ni_NTA (Qiagen, Valencia, CA, USA) affinity column chromatography (Poly-prep, Bio-Rad, Hercules, CA, USA) according to the manufacturer&#8217;s instructions. The concentration of purified protein was then quantified by Bradford assay and stored at &#8722;20&#160;&#176;C for further use.</p></sec><sec id="Sec5"><title>Immunization and challenge</title><p id="Par8">All animal experiments were approved by the Chonbuk National University Animal Ethics Committee (CBNU-2018-00264) in accordance with the guidelines of the Korean Council on Animal Care and Korean Animal Protection Law, 2007; Article 13. All mice used in the study were housed and maintained humanely with the ad libitum supply of antibiotic-free food and water. Five-week old specific pathogen-free female BALB/c mice (<italic toggle="yes">n</italic>&#8201;=&#8201;10) were randomly divided into three groups: PBS control group, vector-only group, or L7/L12 treatment group. Each mouse group was intra-muscularly immunized with phosphate-buffered saline (PBS), <italic toggle="yes">Salmonella</italic> JOL1800 bearing only the vector, or treatment strain harboring pJHL65::L7/L12 at 1&#8201;&#215;&#8201;10<sup>7</sup>&#160;CFU/mice in 100&#160;&#181;L of PBS. On the 14th day post-immunization, blood samples for serum preparation [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] and vaginal washes were collected [<xref ref-type="bibr" rid="CR7">7</xref>] for IgG and sIgA and subtype IgG and IgG2a antibody assessment (<italic toggle="yes">n</italic>&#8201;=&#8201;10). In addition, on the 14th day, five mice from each group were sacrificed for splenocyte collection and used for splenocyte proliferation assay, flow cytometry analysis, and RT-PCR assays. Twenty-one days post-immunization, the remaining mice (<italic toggle="yes">n</italic>&#8201;=&#8201;5) from each group were intraperitoneally challenged with virulent <italic toggle="yes">B. abortus</italic> 544 strain at 2&#8201;&#215;&#8201;10<sup>5</sup>&#160;CFU/mouse. After 14&#160;days of challenge, all mice were euthanized. The total <italic toggle="yes">Brucella</italic> load in whole spleen and liver organs were enumerated by counting colony-forming units using macerated tissue samples as described before [<xref ref-type="bibr" rid="CR7">7</xref>].</p></sec><sec id="Sec6"><title>Antigen-specific IgG and secretory IgA responses</title><p id="Par9">Indirect ELISA (enzyme-linked immunosorbent assay) was used to assess L7/L12 specific IgG and secretory IgA (sIgA) responses in sera and vaginal wash samples, respectively, according to a previous report [<xref ref-type="bibr" rid="CR16">16</xref>] with minor modifications. Briefly, purified L7/L12 protein (300&#160;ng/well) was coated on the ELISA plate overnight at 4&#160;&#176;C in a coating buffer. Plates were washed and blocked with 5% skim milk. Serum samples (1:50) and vaginal washes (without dilution) were incubated for 1&#160;h at 37&#160;&#176;C. Unbound antigen was washed, and plates were incubated with anti-his tag HRP (1:3000). Color development was achieved by adding o-phenylenediamine dihydrochloride (OPD) substrate and was measured at 492&#160;nm wavelength. Further, serum collected at 3rd&#160;week post-immunization was assessed in ELISA against L7/L12 purified protein, <italic toggle="yes">Brucella</italic> whole cell lysate and <italic toggle="yes">Salmonella</italic> whole cell lysate following the same procedure.</p></sec><sec id="Sec7"><title>Antigen-specific splenocyte proliferation assay</title><p id="Par10">Antigen-specific cell-mediated immune responses (CMI) were evaluated in a splenocyte proliferation assay. Splenocytes from mice (<italic toggle="yes">n</italic>&#8201;=&#8201;5) in each PBS control, vector alone, and <italic toggle="yes">Salmonella</italic> L7/L12 groups were harvested at 2 and 3&#160;weeks of post-immunization. Cell number was adjusted to 1&#8201;&#215;&#8201;10<sup>5</sup>&#160;cells/well in 96-well plates and seeded in replicates using RPMI medium supplemented with 10% FBS. Next, cells were stimulated with specific purified L7/L12 protein 10&#160;&#956;g/mL or RPMI media alone. Three days later, cell proliferative response was evaluated by MTT [3-(4,5Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] based assay as described in an earlier report [<xref ref-type="bibr" rid="CR17">17</xref>]. The stimulation index was calculated compared to the responses received in PBS control group. To further confirm the CMI response, the same experiment was repeated at 3rd week post-immunization and stimulation either with purified <italic toggle="yes">Brucella</italic> L7/L12 protein or <italic toggle="yes">B. abortus</italic> whole cell lysate (10<sup>7</sup>&#160;CFU/mL). Splenocytes collected at 3&#160;weeks post-immunization were tested against L7/L12 purified protein and <italic toggle="yes">Brucella</italic> whole cell lysate for comparison.</p></sec><sec id="Sec8"><title>Cytokine responses</title><p id="Par11">Splenocytes from immunized mice were aseptically harvested using five mice per group. Splenocytes (1&#8201;&#215;&#8201;10<sup>6</sup>&#160;cells/mL) were stimulated with 200&#160;ng of the respective purified L7/L12 antigen protein for 24&#160;h. Total RNA was isolated by RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer&#8217;s instructions. Complementary DNA was prepared from 1&#160;&#956;g of RNA using ReverTra Ace qPCR RT Master Mix (TOYOBO, Osaka, Japan) according to the manufacturer&#8217;s instructions and stored at &#8722;20&#160;&#176;C until use. Real-time PCR assay (qRT-PCR) for gene expression studies was performed with ABI applied biosystems using Power SYBR Green PCR Master Mix (#4367659, Applied Biosystems, USA) as previously described [<xref ref-type="bibr" rid="CR18">18</xref>]. The relative amounts of IFN-&#947;, IL-4, and IL-17 were determined by 2<sup>&#8722;&#916;&#916;CT</sup> method [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec9"><title>Flow cytometry</title><p id="Par12">Flow cytometric analysis of CD4+ and CD8+ T cell populations were carried out on mice splenocytes (<italic toggle="yes">n</italic>&#8201;=&#8201;5) harvested on the 14th-day post-primary immunization, as previously described [<xref ref-type="bibr" rid="CR7">7</xref>]. Briefly, 2&#8201;&#215;&#8201;10<sup>5</sup> viable cells were stimulated with <italic toggle="yes">Brucella</italic> whole cell lysate antigen (10&#160;&#956;g/mL) or RPMI media alone for 24&#160;h at 37&#160;&#176;C in 5% CO<sub>2</sub> atmosphere. Cells were then harvested and stained with PE-labeled anti-CD3e, PerCPVio700-labeled anti-CD4, and FITC-labeled anti-CD8a monoclonal antibodies, as previously described [<xref ref-type="bibr" rid="CR20">20</xref>]. The CD3+ T cell population was gated to analyze CD3+ CD4+ and CD3+ CD8+ subpopulations in both vaccinated and control mice groups using a MACSQuant<sup>&#174;</sup> analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany).</p></sec><sec id="Sec10"><title>Statistical analysis</title><p id="Par13">All data were analyzed using the GraphPad Prism 6.00 program (San Diego, CA, USA). One way analysis of variance (ANOVA) with Tukey&#8217;s multiple comparison test was conducted to determine statistical differences among vaccinated and control groups. <italic toggle="yes">P</italic> values&#8201;&lt;&#8201;0.05 were considered statistically significant.</p></sec></sec><sec id="Sec11"><title>Results</title><sec id="Sec12"><title>Confirmation of <italic toggle="yes">Salmonella</italic> secreted <italic toggle="yes">Brucella</italic> antigen</title><p id="Par14">The gene of <italic toggle="yes">B. abortus</italic> ribosomal protein L7/L12 was amplified by PCR using <italic toggle="yes">B. abortus</italic> 544 strain and cloned into the pJHL65-<italic toggle="yes">asd</italic> complemented plasmid (Additional file <xref rid="MOESM1" ref-type="media">1</xref>A). The insertion of the L7/L12 gene cassette (0.374&#160;kb) was confirmed by PCR amplification and double digestion of host plasmid with EcoRI and HindIII restriction enzymes. The presence of the plasmid in <italic toggle="yes">Salmonella</italic> transformants was confirmed by colony PCR method. The pJHL65 plasmid provides <italic toggle="yes">bla</italic> secretion signal upstream to the L7/L12 gene cassette. The efficacy of protein secretion was confirmed by Western blot analysis of the culture supernatant, which yielded the target protein antigen with approximately 12.5&#160;kDa (Additional file <xref rid="MOESM1" ref-type="media">1</xref>B).</p></sec><sec id="Sec13"><title><italic toggle="yes">Brucella</italic> antigen-specific systemic IgG and secretory IgA antibody response</title><p id="Par15">The degree of host response towards foreign antigen L7/L12 was assessed by measuring the antigen-specific antibody response in blood serum and mucosal secretions. Efficient elicitation of both IgG and sIgA (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>A) responses indicates the effectiveness of <italic toggle="yes">Salmonella</italic> delivered antigen presentation. Antibody concentrations on the 14th-day post-immunization demonstrate a significant high IgG and sIgA response in the L7/L12 treated mice group compared to the PBS and vector control groups. The specific elicitation of IgG1 and IgG2a antibody subtypes indicates engagement of both Th1 and Th2 type immune response upon <italic toggle="yes">Salmonella</italic> immunization. However, concerning IgA response, and IgG1 and IgG2a antibody subtype response, a significantly high antibody elicitation is evident due to <italic toggle="yes">Salmonella</italic> vector alone. This&#160;suggests that&#160;approximately 50% of IgA response, 55% IgG1, and 45% IgG2a response elicited by the <italic toggle="yes">Salmonella</italic> secreting L7/L12 is attributed&#160;to <italic toggle="yes">Salmonella</italic> itself. Even though the vector alone elicits L7/L12 specific humoral responses, it is clear after statistical comparison that the <italic toggle="yes">Salmonella</italic> L7/L12 strain still generates significantly higher humoral response even after the subtraction of the vector alone responses. Further, to dissect whether L7/L12 specific antibodies can cross react with <italic toggle="yes">Salmonella</italic>, a repeat experiment was carried out by inoculating mouse with purified protein along with PBS, <italic toggle="yes">Salmonella</italic> L7/L12 and <italic toggle="yes">Salmonella</italic> alone controls. Serum was collected after 3&#160;weeks post-immunization tested against L7/L12 purified protein, <italic toggle="yes">Brucella</italic> whole cell lysate and <italic toggle="yes">Salmonella</italic> whole cell lysate (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>B). Herein, the <italic toggle="yes">Salmonella</italic> vector alone response showed a reduced signal against <italic toggle="yes">Brucella</italic> whole cell lysate probably due to competing antigens and impurities present in the lysate. Further, this result confirms that <italic toggle="yes">Brucella abortus</italic> L7/L12 demonstrates a positive reaction against <italic toggle="yes">Salmonella</italic> whole cell lysate suggesting the fact that there can be a cross reaction between L7/L12 antibodies derived against <italic toggle="yes">Salmonella</italic> native L7/L12 antigen and <italic toggle="yes">Salmonella</italic> secreted <italic toggle="yes">Brucella</italic> L7/L12 antigen. It also can be hypothesized, that the antibodies developed against <italic toggle="yes">Brucella</italic> L7/L12 can result in a cross reaction with native <italic toggle="yes">Salmonella</italic> L7/L12 antigen due to higher amino acid sequence identity and homology present between the two species (Additional file <xref rid="MOESM4" ref-type="media">4</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Figure&#160;1</label><caption><p><bold>Humoral immune responses.</bold> Five-week old female BALB/c mice were immunized with PBS, vector-only strain, and <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> L7/L12. Humoral responses in serum and vaginal washes were measured on 14th day post-immunization. <bold>A</bold> Serum IgG response, IgA response in vaginal washes, and serum IgG1 and IgG2a were demonstrated. *Indicates significant difference compared to PBS control (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). Probability values were depicted. <bold>B</bold> The IgG responses at 21st day post-immunization were measured against purified L7/L12 antigen, <italic toggle="yes">Brucella</italic> whole cell lysate and <italic toggle="yes">Salmonella</italic> whole cell lysate were conducted. ***Indicates the significant difference against the PBS control (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="13567_2020_735_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec14"><title>Cell-mediated immune responses</title><p id="Par16">The splenocyte proliferation assay is an indicator of CMI responses. The <italic toggle="yes">Brucella</italic> L7/L12 antigen is known to induce CMI responses. Thus, the retained biological activity of <italic toggle="yes">Salmonella</italic> secreted <italic toggle="yes">Brucella</italic> L7/L12 can be assessed by a MTT based splenocyte proliferation test. On the 14th&#160;day post-immunization, the L7/L12 treated group had significantly high cell proliferation response after re-stimulation of cells with purified L7/L12 protein compared to the PBS and vector control groups (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>A). When the splenocytes were collected at 3&#160;weeks post-immunization and stimulated by L7/L12 purified protein or <italic toggle="yes">Brucella</italic> whole cell lysate, proliferation test results demonstrated a higher specificity towards L7/L12 antigen and reactivity against both purified L7/L12 protein and <italic toggle="yes">Brucella</italic> whole cell lysate at 3rd&#160;week post-immunization. This result indicates that <italic toggle="yes">Salmonella</italic> secreted L7/L12 elicits cell mediated immune responses that react when encounter immunizing antigen. The engagement of both Th1 and Th2 immune responses could be assessed by analyzing cytokine profiles. Herein, representative cytokines IFN-&#947; and IL-4 expression levels show significant increase compared to the PBS control. Here too, vector alone responses also resulted in&#160;a significant difference from the PBS group. These results suggest that&#160;immunization with <italic toggle="yes">Salmonella</italic> secreting L7/L12 elicits a skewed response towards Th1 immune response over Th2 immune response, signifying an essential IFN- &#947; mediated cellular responses (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>C). Furthermore, flow cytometry analysis of splenic T-cell populations after 14&#160;days of immunization showed a significant increase in both CD4+ and CD8+ expressing cell populations. It suggests that <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> L7/L12 antigen activates and increases antigen-specific T-cell responses in the host. The&#160;present results also argue&#160;that <italic toggle="yes">Salmonella</italic> alone elicits a considerable immune response against L7/L12 antigen stimulation.<fig id="Fig2" position="float" orientation="portrait"><label>Figure&#160;2</label><caption><p><bold>Cell mediated immune responses. A</bold> Stimulation index. Mice were immunized with PBS, vector-only strain, and <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> L7/L12. Two weeks post-immunization, 5 mice from each group were sacrificed, and splenocytes were aseptically collected and restimulated with immunizing antigen. Cell proliferative response was measured by MTT based assay after 3&#160;days of incubation. ***Indicates significant difference compared to PBS control; ns: non-significant difference. Significance was determined at <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05. Exact probability is demonstrated on graph. <bold>B</bold> Stimulation index at 3&#160;weeks. The stimulation index was determined at three weeks of immunization against purified L7/L12 antigen and whole <italic toggle="yes">Brucella</italic> cell lysate. ***Indicates the significant difference against the PBS control, ns: non-significant difference. <bold>C</bold> Cytokine response. Mice were immunized with PBS, vector-only strain, and <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> L7/L12. Two weeks post-immunization, 5 mice from each group were sacrificed, and splenocytes were aseptically collected and restimulated with immunizing antigen. After 1&#160;day of incubation, interferon-gamma and IL-4 response were evaluated at mRNA level by quantitative RT-PCR. Fold change of expression is demonstrated. ***Indicates significant difference against PBS control group. Level of significance was determined at <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05. Exact probability value is demonstrated on the graph. <bold>D</bold> Flow cytometry. Mice were immunized with PBS, vector-only strain, and <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> L7/L12. Two weeks post-immunization, 5 mice from each group were sacrificed, and splenocytes were aseptically collected and restimulated with immunizing antigen. After 1&#160;day of incubation, cells were labeled with CD3+. CD4+ and CD8+ specific anti mouse antibodies CD3+: PE, CD4+: PerCP Vio700, CD8+: FITC (Miltenyi Biotec, Gladbach, Germany) and analyzed in Macsquant flow cytometer instrument (Miltenyi Biotec, Gladbach, Germany). Each population was gated and quantified. ***Indicates significant difference against PBS control group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="13567_2020_735_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec15"><title>Protection efficacy against virulent <italic toggle="yes">Brucella</italic> challenge</title><p id="Par17">To investigate the protective efficacy of <italic toggle="yes">Salmonella</italic> delivered L7/L12 antigen against virulent <italic toggle="yes">B. abortus</italic> challenge, all immunized and control mice were challenged with <italic toggle="yes">B. abortus</italic> 544 strain. Two weeks after the challenge, <italic toggle="yes">Brucella</italic> bacterial burden was quantified by plate method with serially diluted tissue samples (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Our results indicate approximately 2 log reduction in bacterial numbers in both spleen and liver samples of the L7/L12 treatment group compared to the PBS and vector-only control groups (Figures <xref rid="Fig3" ref-type="fig">3</xref>A and B). Protective index was calculated by using the statistical formula (y&#8201;=&#8201;log(x/log x), PI&#8201;=&#8201;y<sub>pbs</sub>&#8201;&#8722;&#8201;y<sub>test</sub>) (Figures <xref rid="Fig3" ref-type="fig">3</xref>C and D). In the protection index too, <italic toggle="yes">Salmonella</italic> vector control resulted in a significantly high level of protection compared to the PBS control.<fig id="Fig3" position="float" orientation="portrait"><label>Figure&#160;3</label><caption><p><bold>Protection index.</bold> Protective efficacy was determined after 2&#160;weeks of challenge conducted on 21st day post-immunization. <italic toggle="yes">Brucella</italic> colony count was taken in spleen (<bold>A</bold>) and liver (<bold>B</bold>) tissues in each group (<italic toggle="yes">n</italic>&#8201;=&#8201;5). Colony counts were converted into protective index using the statistical formula (y&#8201;=&#8201;log(x/log x), PI&#8201;=&#8201;y<sub>pbs</sub>&#8201;&#8722;&#8201;y<sub>test</sub>) and presented with standard deviation. ***Indicates the significant difference against PBS control. <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 was considered significantly different.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="13567_2020_735_Fig3_HTML.jpg"/></fig></p></sec></sec><sec id="Sec16"><title>Discussion</title><p id="Par18">The present study uses the highly immunogenic <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 in a <italic toggle="yes">Salmonella</italic> secretion platform as a live attenuated vaccine for brucellosis. The protective efficacy against virulent <italic toggle="yes">Brucella</italic> challenge was assessed in a BALB/c mice model. The&#160;combined elicitation of humoral and cell-mediated immune response clearly suggests that the combination of L7/L12 antigen with a <italic toggle="yes">Salmonella</italic> delivery system can increase the immune stimulation effect of both entities, <italic toggle="yes">Salmonella</italic> and L7/L12. The selected antigen L7/L12 consists of several dominant antigenic epitopes that are surface exposed (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). Thus, efficient antigen processing and presentation are expected. Another significant advantage of L7/L12 ribosomal protein is its high sequence conservation, with more than 99% of its amino acid sequence identified in members of the <italic toggle="yes">Brucella</italic> genus (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Hence, cross-protection is also anticipated. In the present vaccine design, L7/L12 is incorporated into the <italic toggle="yes">Salmonella</italic> type II secretion system [<xref ref-type="bibr" rid="CR21">21</xref>] via fusion with <italic toggle="yes">bla</italic> signal sequence and under the constitutive Ptrc expression promoter. This results in continuous antigen secretion into the surroundings (Additional file <xref rid="MOESM1" ref-type="media">1</xref>B). This may enhance the chances of antigen presentation by <italic toggle="yes">Salmonella</italic> secreting L7/L12 antigen as the <italic toggle="yes">Salmonella</italic> can penetrate the host tissues including the lymphoid organs such as spleen and liver [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par19">Despite recent research advancements in DNA vaccine technology, the efficacy of DNA delivery remains poor and insufficient for single-dose immunization [<xref ref-type="bibr" rid="CR24">24</xref>]. This is true for both living and non-living DNA carriers during immunization procedures. Immunizations in the form of purified proteins have their limitations, such as high processing cost, requirement for multiple booster applications, and potential for degradation [<xref ref-type="bibr" rid="CR25">25</xref>]. Such practical inefficacies were minimized in the present <italic toggle="yes">Salmonella</italic> mediated immunization strategy because the antigen is readily secreted by <italic toggle="yes">Salmonella</italic> and is available for immune stimulation (Additional file <xref rid="MOESM1" ref-type="media">1</xref>B). IFN-&#947; mediated cellular immune responses are considered essential factors for efficient elimination of intracellular <italic toggle="yes">Brucella</italic> [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. This is the main objective expected from <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 as it can induce essential CMI responses for intracellular elimination of <italic toggle="yes">Brucella</italic> [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In the present study, immunization with <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> ribosomal protein in a single dose clearly induced both IgG and IgA (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>) humoral antibody responses [<xref ref-type="bibr" rid="CR20">20</xref>]. These responses play a vital role in host protection during the early phase of <italic toggle="yes">Brucella</italic> infection on mucosal surfaces [<xref ref-type="bibr" rid="CR27">27</xref>]. On mucosal tissues, complement-mediated killing effectively reduces internalization of <italic toggle="yes">Brucella</italic> pathogen into epithelial cells. Once <italic toggle="yes">Brucella</italic> becomes an intracellular pathogen, the IFN-&#947; cytokine-mediated Th1 immune response is crucial [<xref ref-type="bibr" rid="CR28">28</xref>]. In the present investigation, immunization with <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> L7/L12 protein&#160;induced both CMI (Figures <xref rid="Fig2" ref-type="fig">2</xref>A and B) and IFN-&#947; (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>C) responses significantly more than in PBS and vector control mice. An increase in the&#160;frequency of CD4+ and CD8+ T-cell populations also provides evidence for both Th1 and Th2 immune responses. Particularly, stimulation of CD8+ markers on T-cells can be attributed to L7/L12 induced Th1 immunity, as they were significantly higher in L7/L12 immunized mice than in the vector control group. The challenge conducted with virulent <italic toggle="yes">B. abortus</italic> 544 strains showed clear reduction in <italic toggle="yes">Brucella</italic> populations in spleen and liver tissues in the <italic toggle="yes">Salmonella</italic> vaccine immunized group compared to the vector and PBS control groups, resulting in a significantly higher protection index (Figures <xref rid="Fig3" ref-type="fig">3</xref>A and D) and demonstrating the overall effectiveness of the immunization among test groups.</p><p id="Par20">Considering the antigen specific immune responses in the form of humoral, CMI, and cytokine induction, <italic toggle="yes">Salmonella</italic> vector alone has delivered a considerably high expression levels. We hypothesize this observation may occur particularly due to amino acid sequence and epitope conservation of L7/L12 antigen between <italic toggle="yes">Brucella</italic> and <italic toggle="yes">Salmonella</italic> species&#160;(Additional file <xref rid="MOESM4" ref-type="media">4</xref>). These two species not only share highly similar antigenic epitopes but also demonstrate over 57% amino acid sequence identity (95% query cover&#8201;&#215;&#8201;60.50% percent identity) suggesting the possibility for antibody cross reactions generated in mice against the native <italic toggle="yes">Salmonella</italic> L7/L12 and <italic toggle="yes">Salmonella</italic> secreted <italic toggle="yes">Brucella</italic> L7/L12 antigen. However, the reduction in bacterial colonization in spleen and liver tissues by <italic toggle="yes">Salmonella</italic> vector control may be&#160;partially attributed to <italic toggle="yes">Salmonella</italic> induced non-specific immune stimulation signified by increased IFN-&#947; response.</p><p id="Par21">Safety considerations play a crucial role before live vaccine strains can reach clinical studies. The present JOL1800 strain did not induce any mortality in immunized mice due to attenuation caused by the deletion of <italic toggle="yes">lon</italic>, <italic toggle="yes">cpxR</italic>, and <italic toggle="yes">rfaL</italic> genes [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. The safety of the strain has been extensively proven in our previous studies conducted in mice models. Adding further advantage to the vaccine strain, deletion of the <italic toggle="yes">rfaL</italic> gene confers DIVA capability [<xref ref-type="bibr" rid="CR13">13</xref>] due to removal of a major immunodominant component from the O-antigen. Therefore, the vaccine may be applied with minimum effects from pre-existing lipopolysaccharides (LPS specific) anti-<italic toggle="yes">Salmonella</italic> immunity of the immunizing host [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par22">In the present study, we demonstrated that mice immunized with <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> ribosomal protein L7/L12 could harness both humoral and CMI responses essential for the effective elimination of intracellular pathogen <italic toggle="yes">Brucella.</italic> Here, a single dose of immunization provides a practically convenient vaccination strategy suitable for field conditions. Further research can investigate <italic toggle="yes">Salmonella</italic> secreting L7/L12 fusion proteins with other immunodominant <italic toggle="yes">Brucella</italic> antigens, such as SodC and Omp19 [<xref ref-type="bibr" rid="CR9">9</xref>], which may further augment L7/L12 mediated protective immunity.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec17"><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2020_735_MOESM1_ESM.tif" position="float" orientation="portrait"><caption><p><bold>Additional file 1.</bold>
<bold>Graphic representation of plasmid construct and confirmation of protein secretion.</bold> (A) Major elements of plasmid pJHL65:: L7/L12 are depicted. Figure is not drawn with actual proportions. (B) Western blot confirmation of protein secretion. Expected size of L7/L12 protein is 12.5&#160;kDa.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2020_735_MOESM2_ESM.tif" position="float" orientation="portrait"><caption><p><bold>Additional file 2.</bold>
<bold>Epitope analysis of L7/L12 is demonstrated.</bold> (A) Graphic representation of predicted epitopes is presented in yellow. (B) Distribution of predicted epitopes on three-dimensional model is demonstrated. (C) Amino acid residues resembled in each epitope are demonstrated in red. Altogether, 5 immunodominant epitopes were predicted.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2020_735_MOESM3_ESM.tif" position="float" orientation="portrait"><caption><p><bold>Additional file 3.</bold>
<bold>High degree of L7/L12 sequence conservation is demonstrated within</bold>
<bold><italic toggle="yes">Brucella</italic></bold>
<bold>taxid</bold>. Only variable residues were demonstrated in white boxes. Phylogenetic tree constructed on maximum likelihood method also demonstrates extremely high level of sequence identity. Branch length resembles the number of amino acid residue substitutions in each species. Figures were generated by Phylogeny.fr program and Unipro UGENE.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2020_735_MOESM4_ESM.tif" position="float" orientation="portrait"><caption><p><bold>Additional file 4.</bold>
<bold>Sequence homology.</bold> (A) The homology of B cell epitopes were compared between <italic toggle="yes">Brucella</italic> and <italic toggle="yes">Salmonella</italic> L7/L12 antigen. (B) The sequence identity was determined between <italic toggle="yes">Brucella</italic> and <italic toggle="yes">Salmonella</italic> L7/L12 antigen using Muscle algorithm in Ugene software. The squares depict the predicted B-cell epitopes on <italic toggle="yes">Brucella</italic> L7/L12 antigen.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13567-020-0735-y.</p></sec><ack><title>Acknowledgements</title><p>This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1A6A1A03033084).</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>AS and JHL participated in the designing of the study. AS and CH performed the experiments. AS and CH analyzed the data. AS wrote the manuscript. AS and JHL reviewed and prepared the final version of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par23">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Reichow</surname><given-names>S</given-names></name><name name-style="western"><surname>Ramamoorthy</surname><given-names>S</given-names></name><name name-style="western"><surname>Ding</surname><given-names>X</given-names></name><name name-style="western"><surname>Lathigra</surname><given-names>R</given-names></name><name name-style="western"><surname>Craig</surname><given-names>JC</given-names></name><name name-style="western"><surname>Sobral</surname><given-names>BWS</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name></person-group><article-title><italic toggle="yes">Brucella melitensis</italic> triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><fpage>5035</fpage><lpage>5046</lpage><pub-id pub-id-type="doi">10.1128/IAI.01998-05</pub-id><pub-id pub-id-type="pmid">16926395</pub-id><pub-id pub-id-type="pmcid">PMC1594834</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Detilleux</surname><given-names>PG</given-names></name><name name-style="western"><surname>Deyoe</surname><given-names>BL</given-names></name><name name-style="western"><surname>Cheville</surname><given-names>NF</given-names></name></person-group><article-title>Penetration and intracellular growth of <italic toggle="yes">Brucella abortus</italic> in nonphagocytic cells in vitro</article-title><source>Infect Immun</source><year>1990</year><volume>58</volume><fpage>2320</fpage><lpage>2328</lpage><pub-id pub-id-type="doi">10.1128/IAI.58.7.2320-2328.1990</pub-id><pub-id pub-id-type="pmid">2114362</pub-id><pub-id pub-id-type="pmcid">PMC258815</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Skyberg</surname><given-names>JA</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Clapp</surname><given-names>B</given-names></name><name name-style="western"><surname>Thornburg</surname><given-names>T</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Progress in <italic toggle="yes">Brucella</italic> vaccine development</article-title><source>Front Biol</source><year>2013</year><volume>8</volume><fpage>60</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s11515-012-1196-0</pub-id><pub-id pub-id-type="pmcid">PMC3666581</pub-id><pub-id pub-id-type="pmid">23730309</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sathiyaseelan</surname><given-names>J</given-names></name><name name-style="western"><surname>Parent</surname><given-names>MA</given-names></name><name name-style="western"><surname>Zou</surname><given-names>B</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>CL</given-names></name></person-group><article-title>Interferon-&#947; is crucial for surviving a <italic toggle="yes">Brucella abortus</italic> infection in both resistant C57BL/6 and susceptible BALB/c mice</article-title><source>Immunology</source><year>2001</year><volume>103</volume><fpage>511</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.2001.01258.x</pub-id><pub-id pub-id-type="pmid">11529943</pub-id><pub-id pub-id-type="pmcid">PMC1783270</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prusty</surname><given-names>BR</given-names></name><name name-style="western"><surname>Tabassum</surname><given-names>R</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>P</given-names></name><name name-style="western"><surname>Mohini</surname><given-names>S</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>VK</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>BP</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>PK</given-names></name></person-group><article-title>Expression of Omp16 and L7/L12 <italic toggle="yes">Brucella abortus</italic> protective antigens as secretory fusion proteins in mammalian cells</article-title><source>Indian J Biotechnol</source><year>2017</year><volume>16</volume><fpage>289</fpage><lpage>295</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pakzad</surname><given-names>I</given-names></name><name name-style="western"><surname>Rezaee</surname><given-names>A</given-names></name><name name-style="western"><surname>Rasaee</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Tabbaraee</surname><given-names>B</given-names></name><name name-style="western"><surname>Delpisheh</surname><given-names>A</given-names></name></person-group><article-title>Immunogencity of HSA-L7/L12 (<italic toggle="yes">Brucella abortus</italic> ribosomal protein) in an animal model</article-title><source>Iran J Immunol</source><year>2009</year><volume>6</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">19293473</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title><italic toggle="yes">Brucella</italic> lipopolysaccharide reinforced <italic toggle="yes">Salmonella</italic> delivering <italic toggle="yes">Brucella</italic> immunogens protects mice against virulent challenge</article-title><source>Vet Microbiol</source><year>2017</year><volume>205</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2017.05.012</pub-id><pub-id pub-id-type="pmid">28622869</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clapp</surname><given-names>B</given-names></name><name name-style="western"><surname>Skyberg</surname><given-names>JA</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Thornburg</surname><given-names>T</given-names></name><name name-style="western"><surname>Walters</surname><given-names>N</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>4165</fpage><lpage>4174</lpage><pub-id pub-id-type="doi">10.1128/IAI.05080-11</pub-id><pub-id pub-id-type="pmid">21768283</pub-id><pub-id pub-id-type="pmcid">PMC3187253</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Senevirathne</surname><given-names>A</given-names></name><name name-style="western"><surname>Hewawaduge</surname><given-names>C</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Attenuated <italic toggle="yes">Salmonella</italic> secreting <italic toggle="yes">Brucella</italic> protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model</article-title><source>Vet Immunol Immunopathol</source><year>2019</year><volume>209</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2019.02.001</pub-id><pub-id pub-id-type="pmid">30885303</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roland</surname><given-names>KL</given-names></name><name name-style="western"><surname>Brenneman</surname><given-names>KE</given-names></name></person-group><article-title><italic toggle="yes">Salmonella</italic> as a vaccine delivery vehicle</article-title><source>Expert Rev Vaccines</source><year>2013</year><volume>12</volume><fpage>1033</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1586/14760584.2013.825454</pub-id><pub-id pub-id-type="pmid">24053397</pub-id><pub-id pub-id-type="pmcid">PMC3956298</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>KH</given-names></name></person-group><article-title>DNA vaccines: roles against diseases</article-title><source>Germs</source><year>2013</year><volume>3</volume><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.11599/germs.2013.1034</pub-id><pub-id pub-id-type="pmid">24432284</pub-id><pub-id pub-id-type="pmcid">PMC3882840</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hur</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Enhancement of immune responses by an attenuated <italic toggle="yes">Salmonella enterica</italic> serovar Typhimurium strain secreting an <italic toggle="yes">Escherichia coli</italic> heat-labile enterotoxin B subunit protein as an adjuvant for a live <italic toggle="yes">Salmonella</italic> vaccine candidate</article-title><source>Clin Vaccine Immunol</source><year>2011</year><volume>18</volume><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1128/CVI.00407-10</pub-id><pub-id pub-id-type="pmid">21159921</pub-id><pub-id pub-id-type="pmcid">PMC3067354</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Engineering of a rough auxotrophic mutant <italic toggle="yes">Salmonella</italic> Typhimurium for effective delivery</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>25441</fpage><lpage>25457</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.25192</pub-id><pub-id pub-id-type="pmid">29876000</pub-id><pub-id pub-id-type="pmcid">PMC5986645</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parasuraman</surname><given-names>S</given-names></name><name name-style="western"><surname>Raveendran</surname><given-names>R</given-names></name><name name-style="western"><surname>Kesavan</surname><given-names>R</given-names></name></person-group><article-title>Blood sample collection in small laboratory animals</article-title><source>J Pharmacol Pharmacother</source><year>2010</year><volume>1</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.4103/0976-500X.72350</pub-id><pub-id pub-id-type="pmid">21350616</pub-id><pub-id pub-id-type="pmcid">PMC3043327</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuck</surname><given-names>MK</given-names></name><name name-style="western"><surname>Chan</surname><given-names>DW</given-names></name><name name-style="western"><surname>Chia</surname><given-names>D</given-names></name><name name-style="western"><surname>Godwin</surname><given-names>AK</given-names></name><name name-style="western"><surname>Grizzle</surname><given-names>WE</given-names></name><name name-style="western"><surname>Krueger</surname><given-names>KE</given-names></name><name name-style="western"><surname>Rom</surname><given-names>W</given-names></name><name name-style="western"><surname>Sanda</surname><given-names>M</given-names></name><name name-style="western"><surname>Sorbara</surname><given-names>L</given-names></name><name name-style="western"><surname>Stass</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>DE</given-names></name></person-group><article-title>Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group</article-title><source>J Proteome Res</source><year>2009</year><volume>8</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1021/pr800545q</pub-id><pub-id pub-id-type="pmid">19072545</pub-id><pub-id pub-id-type="pmcid">PMC2655764</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Won</surname><given-names>G</given-names></name><name name-style="western"><surname>Hajam</surname><given-names>IA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Improved lysis efficiency and immunogenicity of <italic toggle="yes">Salmonella</italic> ghosts mediated by co-expression of &#955; phage holin-endolysin and &#968;x174 gene E</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>45139</fpage><pub-id pub-id-type="doi">10.1038/srep45139</pub-id><pub-id pub-id-type="pmid">28332591</pub-id><pub-id pub-id-type="pmcid">PMC5362813</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denizot</surname><given-names>F</given-names></name><name name-style="western"><surname>Lang</surname><given-names>R</given-names></name></person-group><article-title>Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</article-title><source>J Immunol Methods</source><year>1986</year><volume>89</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(86)90368-6</pub-id><pub-id pub-id-type="pmid">3486233</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hajam</surname><given-names>IA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Preexisting <italic toggle="yes">Salmonella</italic>-specific immunity interferes with the subsequent development of immune responses against the <italic toggle="yes">Salmonella</italic> strains delivering H9N2 hemagglutinin</article-title><source>Vet Microbiol</source><year>2017</year><volume>205</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2017.05.021</pub-id><pub-id pub-id-type="pmid">28622853</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfaffl</surname><given-names>MW</given-names></name></person-group><article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title><source>Nucleic Acids Res</source><year>2001</year><volume>29</volume><fpage>e45</fpage><pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id><pub-id pub-id-type="pmid">11328886</pub-id><pub-id pub-id-type="pmcid">PMC55695</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitry</surname><given-names>M-A</given-names></name><name name-style="western"><surname>Hanot Mambres</surname><given-names>D</given-names></name><name name-style="western"><surname>De Trez</surname><given-names>C</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name><name name-style="western"><surname>Ryffel</surname><given-names>B</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Muraille</surname><given-names>E</given-names></name></person-group><article-title>Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with <italic toggle="yes">Brucella melitensis</italic></article-title><source>J Immunol</source><year>2014</year><volume>192</volume><fpage>3740</fpage><lpage>3752</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302561</pub-id><pub-id pub-id-type="pmid">24646742</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korotkov</surname><given-names>KV</given-names></name><name name-style="western"><surname>Sandkvist</surname><given-names>M</given-names></name><name name-style="western"><surname>Hol</surname><given-names>WGJ</given-names></name></person-group><article-title>The type II secretion system: biogenesis, molecular architecture and mechanism</article-title><source>Nat Rev Microbiol</source><year>2012</year><volume>10</volume><fpage>336</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2762</pub-id><pub-id pub-id-type="pmid">22466878</pub-id><pub-id pub-id-type="pmcid">PMC3705712</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>P</given-names></name><name name-style="western"><surname>Slack</surname><given-names>E</given-names></name><name name-style="western"><surname>Grant</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Hardt</surname><given-names>WD</given-names></name><name name-style="western"><surname>Regoes</surname><given-names>RR</given-names></name></person-group><article-title>Lymph node colonization dynamics after oral <italic toggle="yes">Salmonella</italic> Typhimurium infection in mice</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003532</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003532</pub-id><pub-id pub-id-type="pmid">24068916</pub-id><pub-id pub-id-type="pmcid">PMC3777876</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pham</surname><given-names>OH</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>SJ</given-names></name></person-group><article-title>Protective host immune responses to <italic toggle="yes">Salmonella</italic> infection</article-title><source>Future Microbiol</source><year>2015</year><volume>10</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.2217/fmb.14.98</pub-id><pub-id pub-id-type="pmid">25598340</pub-id><pub-id pub-id-type="pmcid">PMC4323267</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saade</surname><given-names>F</given-names></name><name name-style="western"><surname>Petrovsky</surname><given-names>N</given-names></name></person-group><article-title>Technologies for enhanced efficacy of DNA vaccines</article-title><source>Expert Rev Vaccines</source><year>2012</year><volume>11</volume><fpage>189</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1586/erv.11.188</pub-id><pub-id pub-id-type="pmid">22309668</pub-id><pub-id pub-id-type="pmcid">PMC3293989</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Donaldson</surname><given-names>B</given-names></name><name name-style="western"><surname>Al-barwani</surname><given-names>F</given-names></name><name name-style="western"><surname>Young</surname><given-names>V</given-names></name><name name-style="western"><surname>Hook</surname><given-names>S</given-names></name></person-group><source>Subunit vaccine delivery, Chapter 7</source><year>2015</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ribeiro</surname><given-names>LA</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>V</given-names></name><name name-style="western"><surname>Le Loir</surname><given-names>Y</given-names></name><name name-style="western"><surname>Olivera</surname><given-names>SC</given-names></name><name name-style="western"><surname>Dieye</surname><given-names>Y</given-names></name><name name-style="western"><surname>Piard</surname><given-names>JC</given-names></name><name name-style="western"><surname>Gruss</surname><given-names>A</given-names></name><name name-style="western"><surname>Langella</surname><given-names>P</given-names></name></person-group><article-title>Production and targeting of the <italic toggle="yes">Brucella abortus</italic> antigen L7/L12 in <italic toggle="yes">Lactococcus lactis</italic>: a first step towards food-grade live vaccines against brucellosis</article-title><source>Appl Environ Microbiol</source><year>2002</year><volume>68</volume><fpage>910</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.2.910-916.2002</pub-id><pub-id pub-id-type="pmid">11823235</pub-id><pub-id pub-id-type="pmcid">PMC126665</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasquevich</surname><given-names>KA</given-names></name><name name-style="western"><surname>Iba&#241;ez</surname><given-names>AE</given-names></name><name name-style="western"><surname>Coria</surname><given-names>LM</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>SC</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Zwerdling</surname><given-names>A</given-names></name><name name-style="western"><surname>Barrionuevo</surname><given-names>P</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>FS</given-names></name><name name-style="western"><surname>Seither</surname><given-names>C</given-names></name><name name-style="western"><surname>Warzecha</surname><given-names>H</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name></person-group><article-title>An oral vaccine based on U-Omp19 induces protection against <italic toggle="yes">B. abortus</italic> mucosal challenge by inducing an adaptive IL-17 immune response in mice</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e16203</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0016203</pub-id><pub-id pub-id-type="pmid">21264260</pub-id><pub-id pub-id-type="pmcid">PMC3021544</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paranavitana</surname><given-names>C</given-names></name><name name-style="western"><surname>Zelazowska</surname><given-names>E</given-names></name><name name-style="western"><surname>Izadjoo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoover</surname><given-names>D</given-names></name></person-group><article-title>Interferon-&#947; associated cytokines and chemokines produced by spleen cells from <italic toggle="yes">Brucella</italic>-immune mice</article-title><source>Cytokine</source><year>2005</year><volume>30</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2004.12.009</pub-id><pub-id pub-id-type="pmid">15804600</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Won</surname><given-names>G</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Potent O-antigen-deficient (rough) mutants of <italic toggle="yes">Salmonella</italic> Typhimurium secreting <italic toggle="yes">Lawsonia intracellularis</italic> antigens enhance immunogenicity and provide single-immunization protection against proliferative enteropathy and salmonellosis in a murine model</article-title><source>Vet Res</source><year>2018</year><volume>49</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.1186/s13567-018-0552-8</pub-id><pub-id pub-id-type="pmid">29976253</pub-id><pub-id pub-id-type="pmcid">PMC6034208</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>